在生育与代谢的十字路口:AMPK依赖性信号在高雄激素相关女性不孕中的重要性
本研究在小鼠颗粒细胞和人颗粒细胞中探讨能量感受器AMPK信号与高雄激素的关系。沉默α1AMPK可促进KGN细胞增殖、诱导高雄激素反应;α1AMPK敲除雌鼠排卵率下降30%、产仔数减少并出现高雄激素反应;瘦型PCOS女性原代颗粒细胞α1AMPK mRNA表达低于对照组。
要点
- 沉默KGN细胞α1AMPK可促进增殖并诱导高雄激素反应。
- α1AMPK敲除雌鼠排卵率下降30%、产仔数减少并出现高雄激素反应。
- 瘦型PCOS女性原代颗粒细胞α1AMPK mRNA表达低于对照组。
核心结论
- AMPK直接参与人颗粒细胞的类固醇生成,其信号与其他PCOS模型中常报告的功能障碍过程相关。
- 作者认为评估α1AMPK亚基表达可考虑作为激素失衡和代谢紊乱相关不孕(包括PCOS)的标志物。
研究设计与样本
- 研究用CRISPR/Cas9在永生化人颗粒细胞KGN中沉默α1AMPK并分析差异基因表达。
- 体内研究采用α1AMPK敲除小鼠模型评估其在卵泡发育和生育中的作用。
- 评估来自接受IVF女性(瘦型PCOS表型BMI 18-25 kg/m2与无PCOS)的原代人颗粒黄体细胞中α1AMPK表达。
- α1AMPK基因表达用定量RT-PCR在瘦型PCOS女性(n=8)和无PCOS女性(n=9)的原代颗粒细胞中评估。
主要发现
- KGN细胞沉默α1AMPK增加细胞增殖(P < 0.05,与对照相比,n=4)。
- KGN细胞沉默α1AMPK促进脂肪酸利用优于葡萄糖,并通过上调3βHSD和P450scc诱导高雄激素反应(P < 0.05,n=3)。
- α1AMPK缺陷雌鼠较对照排卵率下降30%(P < 0.05,n=7),产仔数减少,出现高雄激素反应(P < 0.05,n=7)伴卵巢3βHSD和p450scc水平升高,窦卵泡群体增加(P < 0.01,n=10)。
- 瘦型PCOS女性原代颗粒细胞α1AMPK mRNA表达水平低于对照组(P < 0.05,n=8-9)。
关键数值与推荐
- 沉默α1AMPK的KGN细胞增殖较对照增加(P < 0.05,n=4)。
- α1AMPK缺陷雌鼠排卵率较对照下降30%(P < 0.05,n=7)。
- α1AMPK缺陷雌鼠窦卵泡群体较对照增加(P < 0.01,n=10)。
- 瘦型PCOS女性原代颗粒细胞α1AMPK mRNA表达低于对照组(P < 0.05,n=8-9)。
临床怎么用
- 作者认为评估α1AMPK亚基表达可考虑作为激素失衡和代谢紊乱相关不孕(包括PCOS)的标志物。
局限性
- 人KGN细胞是未完全分化的转化细胞系。
- 本研究使用的PCOS患者数量少。
- 人颗粒细胞的收集在激素刺激后进行。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What biological processes are linked to the signaling of the energy sensor 5'-AMP-activated protein kinase (AMPK) in mouse and human granulosa cells (GCs)? SUMMARY ANSWER: The lack of α1AMPK in GCs impacted cell cycle, adhesion, lipid metabolism and induced a hyperandrogenic response. WHAT IS KNOWN ALREADY: AMPK is expressed in the ovarian follicle, and its activation by pharmacological medications, such as metformin, inhibits the production of steroids. Polycystic ovary syndrome (PCOS) is responsible for infertility in approximately 5-20% of women of childbearing age and possible treatments include reducing body weight, improving lifestyle and the administration of a combination of drugs to improve insulin resistance, such as metformin. STUDY DESIGN, SIZE, DURATION: AMPK signaling was evaluated by analyzing differential gene expression in immortalized human granulosa cells (KGNs) with and without silencing α1AMPK using CRISPR/Cas9. In vivo studies included the use of a α1AMPK knock-out mouse model to evaluate the role of α1AMPK in folliculogenesis and fertility. Expression of α1AMPK was evaluated in primary human granulosa-luteal cells retrieved from women undergoing IVF with and without a lean PCOS phenotype (i.e. BMI: 18-25 kg/m2). PARTICIPANTS/MATERIALS, SETTING, METHODS: α1AMPK was disrupted in KGN cells and a transgenic mouse model. Cell viability, proliferation and metabolism were evaluated. Androgen production was evaluated by analyzing protein levels of relevant enzymes in the steroid pathway by western blots, and steroid levels obtained from in vitro and in vivo models by mass spectrometry. Differential gene expression in human GC was obtained by RNA sequencing. Analysis of in vivo murine folliculogenesis was performed by histology and immunochemistry, including evaluation of the anti-Müllerian hormone (AMH) marker. The α1AMPK gene expression was evaluated by quantitative RT-PCR in primary GCs obtained from women with the lean PCOS phenotype (n = 8) and without PCOS (n = 9). MAIN RESULTS AND THE ROLE OF CHANCE: Silencing of α1AMPK in KGN increased cell proliferation (P < 0.05 versus control, n = 4), promoted the use of fatty acids over glucose, and induced a hyperandrogenic response resulting from upregulation of two of the enzymes involved in steroid production, namely 3β-hydroxysteroid dehydrogenase (3βHSD) and P450 side-chain cleavage enzyme (P450scc) (P < 0.05, n = 3). Female mice deficient in α1AMPK had a 30% decrease in their ovulation rate (P < 0.05, n = 7) and litter size, a hyperandrogenic response (P < 0.05, n = 7) with higher levels of 3βHSD and p450scc levels in the ovaries, and an increase in the population of antral follicles (P < 0.01, n = 10) compared to controls. Primary GCs from lean women with PCOS had lower α1AMPK mRNA expression levels than the control group (P < 0.05, n = 8-9). LARGE SCALE DATA: The FastQ files and metadata were submitted to the European Nucleotide Archive (ENA) at EMBL-EBI under accession number PRJEB46048. LIMITATIONS, REASONS FOR CAUTION: The human KGN is a not fully differentiated, transformed cell line. As such, to confirm the role of AMPK in GC and the PCOS phenotype, this model was compared to two others: an α1AMPK transgenic mouse model and primary differentiated granulosa-lutein cells from non-obese women undergoing IVF (with and without PCOS). A clear limitation is the small number of patients with PCOS utilized in this study and that the collection of human GCs was performed after hormonal stimulation. WIDER IMPLICATIONS OF THE FINDINGS: Our results reveal that AMPK is directly involved in steroid production in human GCs. In addition, AMPK signaling was associated with other processes frequently reported as dysfunctional in PCOS models, such as cell adhesion, lipid metabolism and inflammation. Silencing of α1AMPK in KGN promoted folliculogenesis, with increases in AMH. Evaluating the expression of the α1AMPK subunit could be considered as a marker of interest in infertility cases related to hormonal imbalances and metabolic disorders, including PCOS. STUDY FUNDING/COMPETING INTEREST(S): This study was financially supported by the Institut National de la Recherche Agronomique (INRA) and the national programme « FERTiNERGY » funded by the French National Research Agency (ANR). The authors report no intellectual or financial conflicts of interest related to this work. R.K. is identified as personnel of the International Agency for Research on Cancer/World Health Organization. R.K. alone is responsible for the views expressed in this article and she does not necessarily represent the decisions, policy or views of the International Agency for Research on Cancer/World Health Organization. TRIAL REGISTRATION NUMBER: N/A.
引用
- Froment P, Plotton I, Giulivi C, et al. At the crossroads of fertility and metabolism: the importance of AMPK-dependent signaling in female infertility associated with hyperandrogenism. Hum Reprod. 2022. PMID: 35459945. doi:10.1093/humrep/deac067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。